Dr. Wilson Constantine, president & CEO of Monarch Medical, on his path to the corner office of a spinout company and his plans for the diabetes market.
Monarch Medical's mission is to transform how hospitals and caregivers handle "drugs of concern," or compounds that, when mismanaged, can lead to injuries or even death – the aptly named "never events" that ought to be anathema to healthcare.
Formed from the EndoTool division of...
Life science companies are counting down to August 1, when new federal Sunshine rules go live. MassDevice.com sits down with compliance attorney Jennifer Geetter to talk about the biggest challenges facing companies during the final countdown, and what the industry can expect from regulators in the future.
With 7 days until the federal Sunshine rules kick in, companies are hammering out the final details of their physician payment reporting strategies, but they'd do well to look beyond the August 1 deadline.
Beyond mere compliance with regulation, companies need to consider how they'll handle public...
MassDevice.com talks with the co-founder and CEO of the largest private spine company, K2M's Eric Major, about the medical device company's technology to treat complex conditions of the spine.
Revenues in the spine industry have been flat for several years now, with the largest players in the space reporting declines or low-single-digit growth.
Earlier this year...
T2 Biosystems CEO John McDonough tells MassDevice.com why the medical device company's MRI-based diagnostics tool could revolutionize diagnostics and save millions of lives in the process.
When MassDevice.com last spoke with T2 Biosystems CEO John McDonough, in August 2009, the 22-worker firm was still developing a novel use for MRI technology – diagnostics.
T2's device uses magnetic resonance to identify pathogens in just about any kind of sample, eliminating the need for time-consuming blood culture work.
Nearly 4 years later, after a move from Cambridge, Mass., to...
Glooko CEO Rick Altinger tells MassDevice.com that the future of chronic disease management depends on patient engagement, smarter mobile technologies and industry partnerships.
Silicon Valley mHealth company Glooko is rocketing forward in the mobile diabetes management space since its inception less than 3 years ago, boasting multiple FDA clearances, wide-ranging industry partnerships and a growing base of patient users and healthcare provider subscribers.
Just last month,...
Medtronic CEO Omar Ishrak speaks with MassDevice.com publisher Brian Johnson about an evolving global medical device landscape, the shifting values of consumers and why he’s not too worried about fighting the medical device tax.